摘要
目的探讨参麦针剂治疗慢性肺源性心脏病(肺心病)低氧血症及酸碱失衡的疗效。方法回顾性分析应用参麦针剂进行治疗的15例肺心病低氧血症及酸碱失衡患者(参麦针剂组)的临床资料,并以同期应用西药治疗的14例肺心病低氧血症及酸碱失衡患者(对照组)作对照,评价其疗效。结果参麦针剂组治疗前后动脉血氧分压(Pa02)、血氧饱和度(Sp02)、碱剩余(BE)水平差异均有统计学意义(P<0.05或P<0.01),但2组治疗前后酸碱平衡的变化无显著性差异(P>0.05)。结论参麦针剂对酸碱失衡虽无明显的影响,但能显著提高Pa02、Sp02水平,从而能明显改善肺心病患者低氧血症症状。
Objective To study the therapeutic effect of Shenmai injection on hypoxemia and acid-base imbalance of chronic pulmonary heart disease. Methods Retrospective analysis of clinical data of 15 patients with pulmonary heart hypox- emia and acid-base imbalance（ Shenmai injection group） Shenmai injection treatment, and the western medicine treatment for the same period 14 patients with pulmonary heart hypoxemia and acid-base imbalance（ control group） as a control,to evaluate their efficacy. Results Before and after treatment, the level of PaO2 ,SaO2 and BE of Shenmai injection group were significant- ly higher than those of control group（ P 〈 0.05 or P 〈 0.01 ）, but the change of acid-base balance had no significant differences between 2 groups （P 〉 0.05 ）. Conclusion Shenmai injection has no noticeable impact on acid-base imbalance, but it can sig- nificantly improve the PaO2 and SaO2 to improve the hypoxemia pulmonary heart disease,
出处
《临床合理用药杂志》
2012年第10期3-4,共2页
Chinese Journal of Clinical Rational Drug Use
关键词
参麦针剂
心脏病
慢性
肺源性
低氧血症
酸碱失衡
Shenmai injection
Heart disease,chronic,pulmonary
Hypoxemia
Acid-base imbalance
